Mirum Pharmaceuticals Inc (MIRM)
46.26
+2.34
(+5.33%)
USD |
NASDAQ |
Nov 14, 16:00
48.11
+1.85
(+4.00%)
After-Hours: 05:25
Mirum Pharmaceuticals Cash from Investing (Quarterly): -72.72M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -72.72M |
| March 31, 2024 | -0.013M |
| December 31, 2023 | -2.00M |
| September 30, 2023 | -182.76M |
| June 30, 2023 | 50.55M |
| March 31, 2023 | 27.02M |
| December 31, 2022 | 26.76M |
| September 30, 2022 | -79.53M |
| June 30, 2022 | 23.97M |
| March 31, 2022 | 36.50M |
| December 31, 2021 | 108.02M |
| Date | Value |
|---|---|
| September 30, 2021 | -2.237M |
| June 30, 2021 | -24.46M |
| March 31, 2021 | -32.78M |
| December 31, 2020 | -4.946M |
| September 30, 2020 | -18.91M |
| June 30, 2020 | 27.97M |
| March 31, 2020 | 33.76M |
| December 31, 2019 | -5.144M |
| September 30, 2019 | -64.19M |
| June 30, 2019 | -58.40M |
| March 31, 2019 | -0.044M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-182.76M
Minimum
Sep 2023
108.02M
Maximum
Dec 2021
-4.787M
Average
-2.00M
Median
Dec 2023
Cash from Investing (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 84.78M |
| Cytokinetics Inc | -45.05M |
| Amicus Therapeutics Inc | 34.27M |
| MannKind Corp | -41.26M |
| TG Therapeutics Inc | -9.334M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.803M |
| Cash from Financing (Quarterly) | 7.291M |
| Free Cash Flow | -39.22M |
| Free Cash Flow Per Share (Quarterly) | -0.3087 |
| Free Cash Flow to Equity (Quarterly) | -14.99M |
| Free Cash Flow to Firm (Quarterly) | -14.50M |
| Free Cash Flow Yield | -1.86% |